with or without venetoclax
Phase 3Small molecule
with or without venetoclax is one of 5 small molecule programs targeting Adult Acute Myeloid Leukemia. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
5 competitors in Adult Acute Myeloid Leukemia
#DrugCompanyPhaseTrials
1Cytosar
TevaApproved
Revuforj
SSyndax Pharmaceuticals
Approved
with or without venetoclax
IInstitute of Hematology & Blood Diseases Hospital, China
Phase 3
Venclexta
AbbViePreclinical
Cerubidine
HHikma Pharmaceuticals LLC
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Adult Acute Myeloid Leukemia1 trial
Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia
Active, not recruiting·IInstitute of Hematology & Blood Diseases Hospital, China·Phase 2/3·NCT05356169·312 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for with or without venetoclax. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details